Cargando…

Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract with increasing incidence worldwide. Although a deeper understanding of the underlying mechanisms of IBD has led to new therapeutic approaches, treatment options are still limited. Severe adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ries, Markus, Moulari, Brice, Shetab Boushehri, Maryam A., Ali, Mohamed Ehab, Molnar, Daniel, Béduneau, Arnaud, Pellequer, Yann, Lamprecht, Alf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879121/ https://www.ncbi.nlm.nih.gov/pubmed/35214083 http://dx.doi.org/10.3390/pharmaceutics14020352

Ejemplares similares

Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis
por: Yazeji, Tawfek, et al.
Publicado: (2017)

A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides
por: Shetab Boushehri, Maryam A., et al.
Publicado: (2018)

Anti-inflammatory effects of acacia and guar gum in 5-amino salicylic acid formulations in experimental colitis
por: Jhundoo, Henusha D., et al.
Publicado: (2021)

Hyaluronic Acid Increases Anti-Inflammatory Efficacy of Rectal 5-Amino Salicylic Acid Administration in a Murine Colitis Model
por: Jhundoo, Henusha D., et al.
Publicado: (2021)

Polymeric Nanoparticles’ Accumulation in Atopic Dermatitis: Clinical Comparison between Healthy, Non-Lesional, and Lesional Skin
por: Try, Céline, et al.
Publicado: (2023)

Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art
por: Shetab Boushehri, Maryam A., et al.
Publicado: (2020)

Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis
por: Jhundoo, Henusha D., et al.
Publicado: (2020)

Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates
por: Castañeda Ruiz, Angel J., et al.
Publicado: (2022)

Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
por: Abdel-Mottaleb, Mona M. A., et al.
Publicado: (2023)

Ellman's method is still an appropriate method for measurement of cholinesterases activities
por: Shetab-Boushehri, Seyed Vahid
Publicado: (2018)

Dual opposite actions of sodium bicarbonate in treatment of acute organophosphate poisoning
por: Shetab-Boushehri, Seyed Vahid
Publicado: (2019)

Is it right to look for anti-cancer drugs amongst compounds having antioxidant effect?
por: Abdollahi, Mohammad, et al.
Publicado: (2012)

Spray Freeze Dried Lyospheres(®) for Nasal Administration of Insulin
por: Serim, Tuğrul Mert, et al.
Publicado: (2021)

Preparation, characterization and optimization of glipizide controlled release nanoparticles
por: Emami, J., et al.
Publicado: (2014)

InstantDL: an easy-to-use deep learning pipeline for image segmentation and classification
por: Waibel, Dominik Jens Elias, et al.
Publicado: (2021)

Evaluation and improvement of the resilience of a transportation system against epidemic diseases: A system dynamics approach
por: Gorji, Mohammad-Ali, et al.
Publicado: (2023)

Preparation and characterization of a sustained release buccoadhesive system for delivery of terbutaline sulfate
por: Emami, J., et al.
Publicado: (2013)

In vitro and in vivo assessment of hydroxypropyl cellulose as functional additive for enabling formulations containing itraconazole
por: Bachmaier, Rafael D., et al.
Publicado: (2021)

Comparison of liquid-liquid extraction-thin layer chromatography with solid-phase extraction-high-performance thin layer chromatography in detection of urinary morphine
por: Ahadi, Ali, et al.
Publicado: (2011)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
por: Freeman, Hugh J
Publicado: (2013)

Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab Injection
por: Lee, Jin-Hyup, et al.
Publicado: (2017)

Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis
por: Wessman, Laurel L., et al.
Publicado: (2017)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Label-free imaging of 3D pluripotent stem cell differentiation dynamics on chip
por: Atwell, Scott, et al.
Publicado: (2023)

Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
por: Kim, Jae Hyun, et al.
Publicado: (2016)

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
por: Kawalec, Paweł, et al.
Publicado: (2016)

Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
por: Hoffmann, Sebastian, et al.
Publicado: (2018)

Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis
por: Park, Jin-Woo, et al.
Publicado: (2017)

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
por: Suzuki, Yasuo, et al.
Publicado: (2013)

Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab
por: Okabayashi, Shinji, et al.
Publicado: (2017)

Efficacy of infliximab and adalimumab therapy in very early onset, severe ulcerative colitis
por: Rohani, Pejman, et al.
Publicado: (2021)

Atypical Dermatitis Herpetiform and Scalp Psoriasis in Ulcerative Colitis Patient Treated With Adalimumab
por: Alshehri, Hamza, et al.
Publicado: (2023)

Dramatic improvement of severe acne pustolosa after adalimumab in a patient with ulcerative colitis
por: Rispo, Antonio, et al.
Publicado: (2016)

Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis
por: Beilman, Candace L., et al.
Publicado: (2016)

Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
por: Midha, Vandana, et al.
Publicado: (2018)

Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring
por: Wasserbauer, Martin, et al.
Publicado: (2022)

Dynamical decoration of stabilized-microtubules by Tau-proteins
por: Hervy, Jordan, et al.
Publicado: (2019)

Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the Literature
por: LaConti, Joseph J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jhkvngetnn9hu6emn4ggd5essb